Connect with us

Legal & Regulation

Oklahoma’s Medical Cannabis Bill Introduces New Requirements, Now in Effect

Jane Summers

Published

on

Oklahoma’s Medical Cannabis Bill Introduces New Requirements, Now in Effect

Oklahoma’s stance on medical cannabis recently revealed, with new requirements for both patients and business owners reports news outlet, 6 KPVI. Also referred to as the Unity Bill and the House Bill (HB) 2612, which was led by Majority Floor Leader, Jon Echols (R-Oklahoma City) and Senator, Greg McCortney (R-Ada), HB 2612 has granted the Oklahoma Medical Marijuana Authority (OMMA) with “rule-making power”.

What the New Requirements Means for Patients and Doctors…

What does this mean for patients? According to the claims made, licensed patients possessing firearms will still be allowed to do so even though the federal law indicates otherwise.

Additionally, the law permits employers within the “safety sensitive positions,” to consider an employee’s medical status prior to hiring them. This is because patients are deemed better off staying away from any firefighting or hazardous materials handling jobs.

That said, the latter doesn’t apply to patients working elsewhere, who will be protected from discrimination that might arise for the ingestion of marijuana.

Doctors are not allowed to approve patient recommendations given that they are partaking in the dispensary business among others. However, they can request OMMA to end a patient’s license given any reasonable argument made.

Leader of the Oklahoma Cannabis Liberty Alliance, Lawrence Pasternack has since reasoned that dismissing doctor approval is unfair, stressing that,

“There are a lot of pain management patients who are using [cannabis] behind their doctor’s back, and if they get caught, they could get terminated.”

Business Owners Require Certificate of Compliance

Business owners are now required to submit a document that indicates that their goods meet the required specifications, i.e. Certificate of Compliance.

In addition, they are asked to apply, “seed-to-sale tracking,” which has been done to limit any possible illegal products from surfacing. Other changes include packaging and labeling requests, along with the finest details about toxins-testing, potency and age appropriateness.

OMMA will have 90 business days to review and renew business requests, with patients’ application results given within 14 business days.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Disclaimer


Ultimate CBD Guide

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational purposes only.

Got news? Email contact@timesofcbd.com